of daily access, a smaller, insignificant effect (-14%, ns) during the second hour, and a significant reduction again during the fourth hour (-18%, p < 0.01) (Fig. 3B). In contrast to these changes in TG and ethanol intake, gemfibrozil had no effect on chow intake at any time-point (data not shown). These findings demonstrate that a lipid-lowering drug can reduce voluntary intake of ethanol.
